Skip to main content
letter
. 2014 Apr 2;1:139–140. doi: 10.1016/j.ymgmr.2014.02.007

Table 1.

Demographic and pain characteristics in 25 UK adult patients with Pompe disease. Data are given either as median (range) or numbers (percentage).

Characteristic Pompe patients (n = 25)
Median age, years (range) 47 (20–70)
Female, n (%) 13 (52)
Median age at first symptoms, years (range) 25 (2–54)
ERT, n (%)
 Currently receiving 19 (76)
 Discontinuation 2 (8)
 Never 4 (16)
Patients reporting pain in the last 7 days, n (%) 22 (88)



Pain severity score (PSS) (0–10)a
Median PSS (range) 3.9 (0.5–7.5)
Pain severity subgroups
 No pain (rating of 0), n (%)
 Mild pain (1–3), n (%) 10 (45.5)
 Moderate pain (4–6), n (%) 10 (45.5)
 Severe pain (7–10), n (%) 2 (9)



Pain related interference with daily activities
Median pain interference score (range) 3.9 (0–7.5)
General activity, median (range) 4.0 (0–10)
Mood, median, (range) 3.0 (0–10)
Walking ability, median (range) 5.0 (0–10)
Normal work, median (range) 4.0 (0–10)
Relations with other people, median (range) 3.0 (0–10)
Sleep, median (range) 4.0 (0–10)
Enjoyment of life, median (range) 4.0 (0–10)



Quality of life/other patient reported outcomes
Median HADS depression score (range) 8.0 (0–14)
Median HADS anxiety score (range) 7.0 (1–18)
Median SF-36v2 physical component summary score (range) 27 (14–55)
Median SF-36v2 mental component summary score (range) 48 (24–71)
Median Rotterdam Handicap Scale Score (range) 24 (12–36)

HADS — Hospital Anxiety and Depression Score, SF-36v2 — Short Form Health Survey 36 version 2.

a

Pain was scored within the last 7 days.